EASY BIO,Inc. Statistics
Total Valuation
EASY BIO,Inc. has a market cap or net worth of KRW 170.65 billion. The enterprise value is 327.12 billion.
Market Cap | 170.65B |
Enterprise Value | 327.12B |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
Earnings Date | Mar 21, 2025 |
Ex-Dividend Date | Dec 27, 2023 |
Share Statistics
EASY BIO,Inc. has 33.14 million shares outstanding. The number of shares has decreased by -0.13% in one year.
Current Share Class | n/a |
Shares Outstanding | 33.14M |
Shares Change (YoY) | -0.13% |
Shares Change (QoQ) | -0.85% |
Owned by Insiders (%) | 1.34% |
Owned by Institutions (%) | 0.69% |
Float | 16.10M |
Valuation Ratios
The trailing PE ratio is 8.80 and the forward PE ratio is 5.95.
PE Ratio | 8.80 |
Forward PE | 5.95 |
PS Ratio | 0.57 |
PB Ratio | 2.55 |
P/TBV Ratio | 30.91 |
P/FCF Ratio | 3.93 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.82, with an EV/FCF ratio of 7.53.
EV / Earnings | 16.37 |
EV / Sales | 1.06 |
EV / EBITDA | 9.82 |
EV / EBIT | 11.45 |
EV / FCF | 7.53 |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 2.80.
Current Ratio | 1.82 |
Quick Ratio | 0.82 |
Debt / Equity | 2.80 |
Debt / EBITDA | 6.03 |
Debt / FCF | 4.62 |
Interest Coverage | 3.95 |
Financial Efficiency
Return on equity (ROE) is 30.71% and return on invested capital (ROIC) is 8.32%.
Return on Equity (ROE) | 30.71% |
Return on Assets (ROA) | 7.23% |
Return on Capital (ROIC) | 8.32% |
Revenue Per Employee | 2.36B |
Profits Per Employee | 152.57M |
Employee Count | 131 |
Asset Turnover | 1.25 |
Inventory Turnover | 6.13 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.15% in the last 52 weeks. The beta is 0.91, so EASY BIO,Inc.'s price volatility has been similar to the market average.
Beta (5Y) | 0.91 |
52-Week Price Change | +50.15% |
50-Day Moving Average | 4,107.20 |
200-Day Moving Average | 4,069.33 |
Relative Strength Index (RSI) | 79.91 |
Average Volume (20 Days) | 244,627 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EASY BIO,Inc. had revenue of KRW 309.29 billion and earned 19.99 billion in profits. Earnings per share was 584.99.
Revenue | 309.29B |
Gross Profit | 88.52B |
Operating Income | 28.57B |
Pretax Income | 26.53B |
Net Income | 19.99B |
EBITDA | 33.30B |
EBIT | 28.57B |
Earnings Per Share (EPS) | 584.99 |
Balance Sheet
The company has 48.58 billion in cash and 200.85 billion in debt, giving a net cash position of -152.28 billion or -4,595.51 per share.
Cash & Cash Equivalents | 48.58B |
Total Debt | 200.85B |
Net Cash | -152.28B |
Net Cash Per Share | -4,595.51 |
Equity (Book Value) | 71.81B |
Book Value Per Share | 2,021.72 |
Working Capital | 86.99B |
Cash Flow
In the last 12 months, operating cash flow was 48.83 billion and capital expenditures -5.38 billion, giving a free cash flow of 43.45 billion.
Operating Cash Flow | 48.83B |
Capital Expenditures | -5.38B |
Free Cash Flow | 43.45B |
FCF Per Share | 1,311.30 |
Margins
Gross margin is 28.62%, with operating and profit margins of 9.24% and 6.46%.
Gross Margin | 28.62% |
Operating Margin | 9.24% |
Pretax Margin | 8.58% |
Profit Margin | 6.46% |
EBITDA Margin | 10.77% |
EBIT Margin | 9.24% |
FCF Margin | 14.05% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.94%.
Dividend Per Share | 100.00 |
Dividend Yield | 1.94% |
Dividend Growth (YoY) | 33.33% |
Years of Dividend Growth | 1 |
Payout Ratio | 17.41% |
Buyback Yield | 0.13% |
Shareholder Yield | 2.07% |
Earnings Yield | 11.36% |
FCF Yield | 25.46% |
Stock Splits
The last stock split was on December 21, 2020. It was a forward split with a ratio of 5.
Last Split Date | Dec 21, 2020 |
Split Type | Forward |
Split Ratio | 5 |
Scores
EASY BIO,Inc. has an Altman Z-Score of 2.14. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.14 |
Piotroski F-Score | n/a |